Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer-Reference-Cited by-同舟云学术

Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer

Published:1997-02 Issue:3 Volume:75 Page:432-435
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

de Wit R,Sylvester R,Tsitsa C,de Mulder PHM,Sleyfer DT,ten Bokkel Huinink WW,Kaye SB,van Oosterom AT,Boven E,Vermeylen K,Stoter G

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc199771.pdf

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Logarithmic decrease of serum alpha-fetoprotein or human chorionic gonadotropin in response to chemotherapy can distinguish a subgroup with better prognosis among highly malignant intracranial non-germinomatous germ cell tumors;Journal of Neuro-Oncology;2011-02-26

2. Un « effet-pointe » troublant sur l’hCG dosé au cours de la chimiothérapie de rattrapage d’une tumeur trophoblastique chez une jeune femme;Immuno-analyse & Biologie Spécialisée;2010-10

3. Predictive Value of Modeled AUCAFP-hCG, a Dynamic Kinetic Parameter Characterizing Serum Tumor Marker Decline in Patients With Nonseminomatous Germ Cell Tumor;Urology;2010-08

4. American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors;Journal of Clinical Oncology;2010-07-10

5. Germ cell testicular tumors: understanding the kinetics of serum alpha-fetoprotein (AFP) during chemotherapy;ANN BIOL CLIN-PARIS;2008